This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Harold A. Kessler, MD; Constance A. Benson, MD; Pam Urbanski, RN, MSN

Arch Intern Med. 1988;148(11):2496-2497.

Abstract
• We describe two patients with human immunodeficiency virus infection and oral hairy leukoplakia whose tongue lesions resolved on oral zidovudine therapy. During therapy, each patient had a measurable reduction in human immunodeficiency virus antigen corresponding with clinical regression of oral lesions. The clinical course suggests that zidovudine may have contributed to the resolution of these lesions either indirectly through immunologic improvement or through an antiviral effect.

(Arch Intern Med 1988;148:2496-2497)

Author Affiliations
From the Department of Medicine, Section of Infectious Disease (Drs Kessler and Benson and Ms Urbanski), and the Department of Immunology/ Microbiology (Dr Kessler), Rush-Presbyterian—St Luke's Medical Center, Chicago.

Footnotes
Accepted for publication March 1, 1988.

Reprint requests to Department of Medicine, Rush-Presbyterian—St Luke's Medical Center, 1725 W Harrison St, Chicago, IL 60612 (Dr Kessler).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Oral Hairy Leukoplakia and Zidovudine Therapy
PODZAMCZER et al.
Arch Intern Med 1990;150:689-689.
ABSTRACT